ArticleMMWR. Morbidity and mortality weekly report2020
Mass Testing for SARS-CoV-2 in 16 Prisons and Jails - Six Jurisdictions, United States, April-May 2020.
Article in MMWR. Morbidity and mortality weekly report, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
71 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Transmission models of respiratory infections in carceral settings: A systematic review.Epidemics · 2025Pooled it
- The health impacts of the COVID-19 pandemic on adults who experience imprisonment globally: A mixed methods systematic review.PloS one · 2022Pooled it
- Article
- Near-source wastewater surveillance as a non-invasive tool for disease detection in prisons.Scientific reports · 2026Article
- Budget impact of wastewater surveillance for COVID-19 in a large urban jail: an activity-based cost analysis.Frontiers in public health · 2026Article
- Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia.Emerging infectious diseases · 2025Review
- Mass SARS-CoV-2 testing in US correctional facilities during the pandemic: a longitudinal analysis.BMJ public health · 2025Article
- COVID-19 Reproduction Numbers and Long COVID Prevalences in California State Prisons.medRxiv : the preprint server for health sciences · 2024Article
- Racial, Ethnic, Sex, and Age Differences in COVID-19 Cases, Hospitalizations, and Deaths Among Incarcerated People and Staff in Correctional Facilities in Six Jurisdictions, United States, March-July 2020.Journal of racial and ethnic health disparities · 2024Article
- Insights into SARS-CoV-2 Surveillance among Prison Populations in Mato Grosso do Sul, Brazil, in 2022.Viruses · 2024Article
- Article
- Correlation of SARS-CoV-2 in Wastewater and Individual Testing Results in a Jail, Atlanta, Georgia, USA.Emerging infectious diseases · 2024Review
- Lessons Learned from COVID-19 Response in Correctional and Detention Facilities.Emerging infectious diseases · 2024Review
- Dynamic Contact Networks of Residents of an Urban Jail in the Era of SARS-CoV-2.medRxiv : the preprint server for health sciences · 2023Article
- "Feeling Trapped in Prison" Due to the COVID-19 Pandemic: Perceptions and Practices among Healthcare Workers and Prison Staff from a Brazilian Maximum Security Unit.Healthcare (Basel, Switzerland) · 2023Article
- Rates of SARS-CoV-2 transmission between and into California state prisons.medRxiv : the preprint server for health sciences · 2023Article
- COVID-19 Burden in Adult Correctional or Detention Facilities and the Surrounding Communities, January 1, 2020-July 20, 2021.Journal of correctional health care : the official journal of the National Commission on Correctional Health Care · 2023Article
- Attitudes towards COVID-19 vaccination among incarcerated persons in the Federal Bureau of Prisons, June-July 2021.Vaccine · 2023Article
- Article
- Article
11 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preventing coronavirus disease 2019 (COVID-19) in correctional and detention facilities* can be challenging because of population-dense housing, varied access to hygiene facilities and supplies, and limited space for isolation and quarantine (1). Incarcerated and detained populations have a high prevalence of chronic diseases, increasing their risk for severe COVID-19-associated illness and making early detection critical (2,3). Correctional and detention facilities are not closed systems; SARS-CoV-2, the virus that causes COVID-19, can be transmitted to and from the surrounding community through staff member and visitor movements as well as entry, transfer, and release of incarcerated and detained persons (1). To better understand SARS-CoV-2 prevalence in these settings, CDC requested data from 15 jurisdictions describing results of mass testing events among incarcerated and detained persons and cases identified through earlier symptom-based testing. Six jurisdictions reported SARS-CoV-2 prevalence of 0%-86.8% (median = 29.3%) from mass testing events in 16 adult facilities. Before mass testing, 15 of the 16 facilities had identified at least one COVID-19 case among incarcerated or detained persons using symptom-based testing, and mass testing increased the total number of known cases from 642 to 8,239. Case surveillance from symptom-based testing has likely underestimated SARS-CoV-2 prevalence in correctional and detention facilities. Broad-based testing can provide a more accurate assessment of prevalence and generate data to help control transmission (4).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.